Roche Molecular Systems is a company developing, manufacturing and supplying diagnostic and blood screening tests. The company was founded in 1991 in Pleasanton, California, United States, and is a sub-organization of Roche.
The company develops and commercializes diagnostic and blood screening tests based on polymerase chain reaction technologies. Roche Molecular Systems creates products including vitro diagnostic PCR kits, research assays, and automation platforms for the PCR kit processing.
Since the outbreak of COVID-19 (coronavirus), Roche Molecular Systems has begun commercial testing for drugs to combat the virus. The company is looking to provide high-volume testing capabilities to respond to the pandemic, and has been working to bring their cobas 6800/8800 systems test to their patients as the test can perform a SARS-CoV-2 test within three to four hours. The company plans to have millions of tests available each month for the cobas 6800 and 8800 systems. Expediting test development to support urgent needs during the outbreak is the top priority for Roche Molecular Systems.
Pleasanton Company Creates Coronavirus Test Kits
March 14, 2020
Roche Molecular Systems | Crunchbase
Roche's cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- CompanyA company, abbreviated as "Co." within a company name, is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- COVID-19COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the World Health Organization.